Successful in Vitro Fertilization and Embryo Transfer after Transplantation of Cryopreserved Ovarian Tissue: Report of the First Korean Case

Journal of Korean Medical Science
Jung Ryeol LeeSeok Hyun Kim

Abstract

For patients at risk of premature ovarian failure with cancer treatment, it is an important option to re-implant the ovarian tissue (OT) after cryopreservation to preserve endocrine function and fertility. With this technique, about 30% of pregnancy success rate and about 90 live births have been reported to date. However, there has been no case report of successful in vitro fertilization (IVF) and embryo transfer (ET) with oocytes collected from transplanted cryopreserved OT in Korea. We report a 30-year old woman with rectal cancer who underwent IVF and ET after cryopreserved OT thawing and re-implantation. She has been diagnosed with stage IIIC rectal cancer after surgery, and right ovary was removed and cryopreserved between cycles of chemotherapy. After completion of chemotherapy and radiotherapy, the patient underwent orthotopic transplantation of cryopreserved OTs. Three months after transplantation, the serum follicle-stimulating hormone level decreased from 91.11 mIU/mL to 43.69 mIU/mL. Thereafter, the patient underwent 11 ovarian stimulation cycles, and in 7 cycles, follicle growth was observed at the OT graft site. In one of these cycles, the oocyte was successfully retrieved and one embryo was transplanted after IVF...Continue Reading

References

Jan 29, 1999·Endocrinology and Metabolism Clinics of North America·S Howell, S Shalet
Jan 13, 2001·Molecular and Cellular Endocrinology·D Meirow
Mar 24, 2005·Journal of the National Cancer Institute. Monographs·Hilary O D Critchley, W Hamish B Wallace
Jun 24, 2006·Reproductive Biomedicine Online·Gábor Vajta, Zsolt Péter Nagy
May 22, 2008·Reproductive Biomedicine Online·Jacques DonnezMarie-Madeleine Dolmans
May 29, 2009·Human Reproduction Update·I DemeestereY Englert
Sep 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanghoon LeeKutluk Oktay
Jan 14, 2011·Annals of Medicine·Jacques DonnezMarie-Madeleine Dolmans
Aug 15, 2014·Archives of Gynecology and Obstetrics·Silke KlockeGeorg Griesinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.